Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 10, 2025
Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma With a Predilection for the Skeletally Mature
Karen Fritchie, Baptiste Ameline, Vanghelita Andrei, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 14, 2020
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile
Krinio Giannikou, Zachary Zhu, Jaegil Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma
Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak, et al.
Neuro-Oncology
|
May 20, 2021
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results
Wenya Linda Bi, Lakshmi Nayak, David M Meredith, et al.
Neuro-Oncology
|
May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4
Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Neuro-Oncology
|
August 20, 2024
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors
Hia S Ghosh, Ruchit V Patel, Eleanor Woodward, et al.
Blood
|
December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Nature Communications
|
May 15, 2025
Gabapentinoids confer survival benefit in human glioblastoma
Joshua D Bernstock, Mulki Mehari, Jakob V E Gerstl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 10, 2025
Malignant Chondroblastoma: An Epigenetically Distinct Subtype of Chondroblastoma With a Predilection for the Skeletally Mature
Karen Fritchie, Baptiste Ameline, Vanghelita Andrei, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 14, 2020
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile
Krinio Giannikou, Zachary Zhu, Jaegil Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma
Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak, et al.
Neuro-Oncology
|
May 20, 2021
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results
Wenya Linda Bi, Lakshmi Nayak, David M Meredith, et al.
Neuro-Oncology
|
May 29, 2025
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4
Aleksandra B Lasica, Zhou Lan, Julie J Miller, et al.
Neuro-Oncology
|
August 20, 2024
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors
Hia S Ghosh, Ruchit V Patel, Eleanor Woodward, et al.
Blood
|
December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Nature Communications
|
May 15, 2025
Gabapentinoids confer survival benefit in human glioblastoma
Joshua D Bernstock, Mulki Mehari, Jakob V E Gerstl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Page
of 7